Yifan Pharmaceutical Co., Ltd. (SHE:002019)
China
· Delayed Price · Currency is CNY 12.91
-0.36 (-2.71%)
Mar 9, 2026, 3:04 PM CST
Yifan Pharmaceutical Company Description
Yifan Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of pharmaceutical products, raw materials, and polymer materials in Southeast Asia, Europe and North America, Singapore, South Korea, Italy, China, Germany, and the United States.
It offers Chinese patent medicines, chemical medicines and biological medicines; and vitamin products, including vitamin B5 and original B5.
The company was formerly known as Yifan Xinfu Pharmaceutical Co., Ltd. and changed its name to Yifan Pharmaceutical Co., Ltd. in October 2016.
Yifan Pharmaceutical Co., Ltd. was founded in 2000 and is headquartered in Hangzhou, China.
Yifan Pharmaceutical Co., Ltd.
| Country | China |
| Founded | 2000 |
| Industry | Drug Manufacturers - General |
| Sector | Healthcare |
| Employees | 4,098 |
| CEO | Xian Feng Cheng |
Contact Details
Address: No. 50, Qinshan Hangzhou, Zhejiang Province 311300 China | |
| Phone | 86 40 0180 2019 |
| Website | yifanyy.com |
Stock Details
| Ticker Symbol | 002019 |
| Exchange | Shenzhen Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| ISIN Number | CNE000001K65 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Xian Feng Cheng | Chairman of the Board of Directors, President and GM |
| Dawei Zhang | Chief Financial Officer |
| Xing Lin | Deputy GM, Vice President and Director |
| Deqi Feng | Board Secretary, Deputy GM, Vice President and Director |
| Ximing Li | Deputy GM and Vice President |
| Yuhong Geng | Deputy GM and Vice President |
| Kai Wang | Head of Accounting |
| William Tan | Director of Sales Team |